Pathogen Reduction - The Proactive Strategy in Pandemic Preparation to Secure Blood Safety
White Paper: Why Pathogen Reduction? – Use of Pathogen Reduced Platelets for Patient Safety and Sustainability
Case Study – “How do we... integrate pathogen reduced platelets into our hospital blood bank inventory?"-INTERCEPT Blood System
Roswell Park Cancer Insitute – “The Effects of PAS and PR on Platelet Use”-INTERCEPT Blood System
Yale-New Haven Hospital – “Logistical Management of Incorporating Pathogen Reduced Platelets into Inventory”-INTERCEPT Blood System
Rx Only. For CONTRAINDICATIONS and WARNINGS, click here. See package insert for full prescribing information – available on the resource page. There is no pathogen inactivation process that has been shown to eliminate all pathogens. ©2021 Cerus Corporation. All Rights Reserved. INTERCEPT, INTERCEPT Blood System and CERUS are registered trademarks of Cerus Corporation. This site is intended for US audiences only. MKT-EN 00401 v2.0